FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909887958> ?p ?o ?g. }

• W2909887958 endingPage "396" @default.
• W2909887958 startingPage "385" @default.
• W2909887958 abstract "Novel patterns of response and progression to immunotherapy have been reported that are not observed with conventional cytotoxic or targeted anticancer treatments. A major breakthrough with immunotherapy is its potential to achieve durable responses in a subset of patients with advanced cancer that can be maintained several years even after stopping the treatment. No standardized definition of durable response exists in the literature, and the optimal duration of treatment in case of durable response is not clearly established. However, the majority of patients do not respond to immunotherapy. Initially reported in advanced melanoma patients, pseudoprogression occurs when tumor index lesions regress after initial progression, supporting the concept of treating some patients beyond progression. Overall, reported rates of pseudoprogression never exceeded 10%, meaning that the large majority of patients who have a disease progression will not eventually respond to treatment. The decision to pursue treatment beyond progression must therefore only be taken in carefully selected patients with clinical benefit, who did not experience severe toxicities with immunotherapy. Conversely, rapid progressions, called hyperprogressions, were reported by several teams with rates ranging from 4% to 29%. These observations need to be confirmed from randomized trials. It is essential to interrupt the treatment in patients with hyperprogression, in order to switch to another potentially active treatment. Finally, some patients experience dissociated responses, with some lesions shrinking and others growing. Local treatment with surgery or radiotherapy for growing lesions may be considered. Several immune-specific-related response criteria were developed to better capture benefits of immunotherapy. These criteria only address the pseudoprogression pattern of response, and do not capture the other patterns of response such as hyperprogression and dissociated response. The classic RECIST remains a reasonable and meaningful method to assess response to immunotherapy in the clinic." @default.
• W2909887958 created "2019-01-25" @default.
• W2909887958 creator A5015994748 @default.
• W2909887958 creator A5029455802 @default.
• W2909887958 creator A5041145711 @default.
• W2909887958 creator A5046176418 @default.
• W2909887958 creator A5053481267 @default.
• W2909887958 creator A5060793722 @default.
• W2909887958 creator A5063649167 @default.
• W2909887958 creator A5086817406 @default.
• W2909887958 creator A5087565705 @default.
• W2909887958 date "2019-03-01" @default.
• W2909887958 modified "2023-10-18" @default.
• W2909887958 title "Novel patterns of response under immunotherapy" @default.
• W2909887958 cites W1971554504 @default.
• W2909887958 cites W1971837077 @default.
• W2909887958 cites W1986372710 @default.
• W2909887958 cites W2018695684 @default.
• W2909887958 cites W2019607817 @default.
• W2909887958 cites W2059103130 @default.
• W2909887958 cites W2059928795 @default.
• W2909887958 cites W2066671159 @default.
• W2909887958 cites W2076111644 @default.
• W2909887958 cites W2095267413 @default.
• W2909887958 cites W2100158834 @default.
• W2909887958 cites W2104347254 @default.
• W2909887958 cites W2106511606 @default.
• W2909887958 cites W2112121482 @default.
• W2909887958 cites W2125112000 @default.
• W2909887958 cites W2128035403 @default.
• W2909887958 cites W2133075384 @default.
• W2909887958 cites W2147622445 @default.
• W2909887958 cites W2152897456 @default.
• W2909887958 cites W2153778867 @default.
• W2909887958 cites W2156261087 @default.
• W2909887958 cites W2156353875 @default.
• W2909887958 cites W2166602936 @default.
• W2909887958 cites W2166662937 @default.
• W2909887958 cites W2198093519 @default.
• W2909887958 cites W2222086386 @default.
• W2909887958 cites W2296049142 @default.
• W2909887958 cites W2340039278 @default.
• W2909887958 cites W2386935098 @default.
• W2909887958 cites W2465860350 @default.
• W2909887958 cites W2515622316 @default.
• W2909887958 cites W2525217971 @default.
• W2909887958 cites W2529484692 @default.
• W2909887958 cites W2541574334 @default.
• W2909887958 cites W2554618897 @default.
• W2909887958 cites W2582671354 @default.
• W2909887958 cites W2586493371 @default.
• W2909887958 cites W2588078993 @default.
• W2909887958 cites W2588916311 @default.
• W2909887958 cites W2592144107 @default.
• W2909887958 cites W2598988196 @default.
• W2909887958 cites W2601621622 @default.
• W2909887958 cites W2605497049 @default.
• W2909887958 cites W2606976048 @default.
• W2909887958 cites W2607977201 @default.
• W2909887958 cites W2725298133 @default.
• W2909887958 cites W2743577629 @default.
• W2909887958 cites W2746991247 @default.
• W2909887958 cites W2752793362 @default.
• W2909887958 cites W2753890414 @default.
• W2909887958 cites W2762777471 @default.
• W2909887958 cites W2763377972 @default.
• W2909887958 cites W2764212839 @default.
• W2909887958 cites W2765867785 @default.
• W2909887958 cites W2765962239 @default.
• W2909887958 cites W2770312776 @default.
• W2909887958 cites W2779503684 @default.
• W2909887958 cites W2783708539 @default.
• W2909887958 cites W2789072552 @default.
• W2909887958 cites W2791043965 @default.
• W2909887958 cites W2801325974 @default.
• W2909887958 cites W2802607685 @default.
• W2909887958 cites W2831487285 @default.
• W2909887958 cites W2886349478 @default.
• W2909887958 cites W2888264184 @default.
• W2909887958 cites W2891266481 @default.
• W2909887958 cites W2892371440 @default.
• W2909887958 doi "https://doi.org/10.1093/annonc/mdz003" @default.
• W2909887958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30657859" @default.
• W2909887958 hasPublicationYear "2019" @default.
• W2909887958 type Work @default.
• W2909887958 sameAs 2909887958 @default.
• W2909887958 citedByCount "311" @default.
• W2909887958 countsByYear W29098879582019 @default.
• W2909887958 countsByYear W29098879582020 @default.
• W2909887958 countsByYear W29098879582021 @default.
• W2909887958 countsByYear W29098879582022 @default.
• W2909887958 countsByYear W29098879582023 @default.
• W2909887958 crossrefType "journal-article" @default.
• W2909887958 hasAuthorship W2909887958A5015994748 @default.
• W2909887958 hasAuthorship W2909887958A5029455802 @default.
• W2909887958 hasAuthorship W2909887958A5041145711 @default.
• W2909887958 hasAuthorship W2909887958A5046176418 @default.
• W2909887958 hasAuthorship W2909887958A5053481267 @default.

• next